RARE icon

Ultragenyx Pharmaceutical

170 hedge funds and large institutions have $3.74B invested in Ultragenyx Pharmaceutical in 2019 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 75 increasing their positions, 43 reducing their positions, and 26 closing their positions.

Holders
170
Holders Change
-6
Holders Change %
-3.41%
% of All Funds
3.7%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
22
Increased
75
Reduced
43
Closed
26
Calls
$10.4M
Puts
$9.37M
Net Calls
+$1.06M
Net Calls Change
-$10.4M
Name Market Value Shares Shares
Change
Shares
Change %
Stifel Financial
176
Stifel Financial
Missouri
-11,327 Closed
Verition Fund Management
177
Verition Fund Management
Connecticut
-9,378 Closed
DTL
178
Dynamic Technology Lab
Singapore
-8,900 Closed
BCM
179
BlueCrest Capital Management
Jersey
-6,914 Closed
VF
180
Virtu Financial
New York
-6,229 Closed
EMG
181
Ellington Management Group
Connecticut
-6,000 Closed
PAM
182
Panagora Asset Management
Massachusetts
-4,879 Closed
GAM
183
Gotham Asset Management
New York
-4,562 Closed
BCM
184
Bayesian Capital Management
New York
-3,753 Closed
Simplex Trading
185
Simplex Trading
Illinois
-3,593 Closed
OAM
186
Oxford Asset Management
United Kingdom
-3,101 Closed
RJFSA
187
Raymond James Financial Services Advisors
Florida
-2,929 Closed
GCP
188
GSA Capital Partners
United Kingdom
-2,900 Closed
MAM
189
Meeder Asset Management
Ohio
-598 Closed
KPW
190
Kore Private Wealth
New York
-250 Closed
PCM
191
Prelude Capital Management
New York
-129 Closed
MNBTD
192
Moody National Bank Trust Division
Texas
-85 Closed
RFC
193
Regions Financial Corp
Alabama
-11 Closed
CAM
194
Cresset Asset Management
Illinois
-6 Closed
Walleye Trading
195
Walleye Trading
New York
GWS
196
Glassman Wealth Services
Virginia
$0 6
CM
197
Caption Management
Oklahoma
Nomura Asset Management
198
Nomura Asset Management
Japan
GT
199
Glenmede Trust
Pennsylvania
$0 14
CFGS
200
Concourse Financial Group Securities
Alabama